The $2.25B Acquisition of Focused Ultrasound Manufacturer Validates and Advances Field

The recent landmark acquisition of HistoSonics, a leader in focused ultrasound devices, is the most significant milestone in the evolution of the field to date—and a case study in how medical innovation works when government and private capital are combined.    HistoSonics successfully commercialized histotripsy – a technique that uses focused ultrasound to noninvasively liquify target ...